Clinical trial

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

NCT06582875

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-03-06

PhasePHASE2

Study timeline

Study start (actual)2025-03-06Date precision: day

Registry last updated2025-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Autosomal Dominant Polycystic Kidneyunresolved

Obesityunresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Washington University School of Medicinecollaborator

Mayo Cliniccollaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06582875 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.